A. Younes Et Al. , "Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma," JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15, pp.1285-1306, 2019
Younes, A. Et Al. 2019. Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15 , 1285-1306.
Younes, A., Sehn, L. H., Johnson, P., Zinzani, P. L., Hong, X., Zhu, J., ... Patti, C.(2019). Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15, 1285-1306.
Younes, Anas Et Al. "Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma," JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15, 1285-1306, 2019
Younes, Anas Et Al. "Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15, pp.1285-1306, 2019
Younes, A. Et Al. (2019) . "Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.15, pp.1285-1306.
@article{article, author={Anas Younes Et Al. }, title={Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non-Germinal Center B-Cell Diffuse Large B-Cell Lymphoma}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2019, pages={1285-1306} }